EUVIMEDEUVIMED entdecken
Systematische Übersicht

Epstein–Barr virus and inflammatory bowel disease: a systematic review of its clinical significance and potential pathogenic role

Maria Manuela Estevinho iD, Hyder Said iD, Anubhab Nandy, Scott B Snapper, Jean-Frederic Colombel iD, Manasi Agrawal

Inflammatory Bowel Diseases · 10.11.2026

DOI: 10.1093/ibd/izag230 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 10.11.2026. Verfasst von Maria Manuela Estevinho und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Unidade Local de Saúde Gaia Espinho, Vila Nova de Gaia, 4434-502, Portugal. Die Arbeit nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Several studies report an association between Epstein–Barr virus (EBV) and inflammatory bowel disease (IBD). This review critically synthesizes current evidence on these association between EBV and IBD, its potential mechanisms, clinical implications, and research gaps.

Methods

A systematic search identified studies investigating EBV in IBD using serological, molecular, and tissue-based approaches. Data on EBV prevalence, viral load, disease phenotype, treatment status, and clinical outcomes were extracted, and study quality was assessed. A narrative review examined proposed mechanisms that may potentially link EBV to intestinal inflammation.

Results

From 7271 citations, 45 studies met inclusion criteria. EBV was more frequently detected in intestinal tissue from IBD patients than in controls, particularly in active or refractory disease, whereas findings for seroprevalence and blood-based markers were less consistent. Some longitudinal studies reported associations between prior EBV exposure and subsequent IBD, particularly Crohn’s disease, but these observations do not establish a causal relationship. Proposed mechanisms involving EBV-infected B cells, molecular mimicry, and altered cytokine signaling provide biological plausibility but remain unproven in IBD. EBV latency programs and age at seroconversion may influence disease progression and reactivation risk, although data remain limited. Corticosteroids and therapy with infliximab plus azathioprine have been associated with higher EBV loads, especially in refractory disease, yet these findings may be confounded by disease severity and treatment exposure.

Conclusions

Current evidence supports an association between EBV and IBD, particularly in severe and refractory disease but does not establish—and equally does not exclude—a pathogenic role for EBV. Considerable methodological heterogeneity in study design and EBV detection methods and the observational nature of the available data limit causal interpretation. Prospective mechanistic studies are needed to determine whether EBV is a causal contributor, a disease modifier, or a marker of underlying immune dysregulation.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s diseaseEpstein–Barr virusdisease pathogenesisimmune dysregulationinflammatory bowel diseaseulcerative colitisvirus

Autor:innen und Institutionen

  • Department of Gastroenterology, Unidade Local de Saúde Gaia Espinho, Vila Nova de Gaia, 4434-502, Portugal.
  • Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, 4200-319, Portugal.
  • The Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
  • Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, United States.
  • Division of Gastroenterology, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, United States.

ORCID-Profile: Maria Manuela Estevinho, Hyder Said, Jean-Frederic Colombel

Zitieren

APA

Estevinho, M. M., Said, H., Nandy, A., Snapper, S. B., Colombel, J. F., & Agrawal, M. (2026). Epstein–Barr virus and inflammatory bowel disease: a systematic review of its clinical significance and potential pathogenic role. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag230

Vancouver

Estevinho MM, Said H, Nandy A, Snapper SB, Colombel JF, Agrawal M. Epstein–Barr virus and inflammatory bowel disease: a systematic review of its clinical significance and potential pathogenic role. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izag230

BibTeX
@article{Estevinho2026,
  author = {Estevinho, Maria Manuela and Said, Hyder and Nandy, Anubhab and Snapper, Scott B and Colombel, Jean-Frederic and Agrawal, Manasi},
  title = {Epstein–Barr virus and inflammatory bowel disease: a systematic review of its clinical significance and potential pathogenic role},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  doi = {10.1093/ibd/izag230}
}
Kostenlos starten →